News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ESMO: No Help from PARP Inhibitor in Ovarian Cancer, Royal Marsden Hospital Study


10/14/2010 6:12:50 AM

MedPageToday -- MILAN -- Patients with progressive BRCA-related ovarian cancer got no significant benefit from treatment with an agent that targets the PARP pathway, researchers reported here.

Read at MedPageToday

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES